Vascular Cures Team

MeganMegan Patterson

Megan Patterson, Chief Executive Officer, has a diverse background in the life sciences which includes roles in regulatory, marketing, business development, and project management. She has been involved primarily in the translational and clinical development stages of biologic, drug, device and diagnostic products. Megan established the U.S. office for Clinical Network Services, an international CRO and consulting firm focused on late pre-clinical and clinical product development, and played a key role in establishing Coté Orphan Consulting, a regulatory affairs firm for orphan products in Washington, DC. She has also been honored with several awards for her work with non-profits and served as an AmeriCorps*VISTA (Volunteer in Service to America) as a community engagement manager in Ferguson, Missouri. Megan has a BS in Chemistry and Biochemistry, Cell & Molecular Biology from Drake University and a Masters in Business Science Keck Graduate Institute of Applied Life Sciences.

Katelyn Jackson

Katelyn Jackson, Director of Operations & Marketing, brings experience in operations management in healthcare, social services and educational settings. Before Vascular Cures, she was Operations Manager at BrightStar Home Care, managing 70 office and nursing staff members. Katelyn also has a personal history with vascular disease and blood clotting disorders. She holds a bachelor’s and master’s degree in the social sciences.

Lisa Huntzinger

Lisa Huntzinger, Program Manager, oversees Project Voice, an innovative program designed to improve patient outcomes through digital health tools, patient-reported outcomes research and patient empowerment. Before joining Vascular Cures, she held operations and project manager roles for IBM and the Consortium for Service Innovation, a non-profit alliance of organizations focused on innovations in the support industry. She is a graduate of University of California, Berkeley.

David Sayas

David Sayas, Operations Associate, assists the company by performing online marketing and administrative duties. Before Vascular Cures, he was a marketing and social media strategist for Cardinale Automotive Group and Brent Redmond Transportation, managing 40 various marketing accounts for companies all over the U.S. He is currently enrolled at California State University Monterey Bay, and will be receiving his bachelor’s degree in Business Marketing in Fall 2020.Sydney Yu

Sydney Yu
Sydney Yu, Social Media Intern, manages social media pages and analyzes platform performance. Prior to joining the Vascular Cures team, she was an advisor for UC Davis Global Affairs, assisting in outreach and student relations. Sydney is currently a student at the University of California, Davis, and will be receiving a Bachelor’s in Managerial Economics with an emphasis in Business, and Bachelors in Communications in Spring 2020.

Vascular Cures Volunteers

Tim Robb

Tim Robb, collaborator, change agent and consultant brings 40 years of IT and Operations experience to Vascular Cures. Tim’s career spanned several multi-national corporate entities – across a variety of industries – LSI Logic (Semiconductors), Xerox (Imaging), Johnson & Johnson (Medical Devices & Consumer Products) and NetApp (Data Management). Consideration and application of effective Change Management principals were instrumental in setting appropriate user expectations during his career. Tim’s initial engagement with Vascular Cures was on the Project Voice launch at Wake Forest. Tim holds a B.S. in Journalism and an MBA from San Jose State University.

Nipun Bhandari

Nipun is currently a Resident in Internal Medicine at NYU who is applying to a Fellowship in Cardiovascular Medicine. He holds a B.A. from Cornell University, an M.P.H from The Dartmouth Institute for Health Policy and Clinical Practice, and a M.D. from the University of Southern California. His research focuses on peripheral vascular disease, specifically how medical comorbidities such as Chronic Kidney Disease and Diabetes impact outcomes following both surgical and endovascular lower extremity revascularization. His work under renowned physician-scientists Dr. Jeffrey Berger and Dr. Nathaniel Smilowitz has been presented at the American Heart Association’s annual conference and published in cardiovascular journals.